VIRAL MALIGNANT LYMPHOMAGENESIS
病毒恶性淋巴瘤发生
基本信息
- 批准号:3171920
- 负责人:
- 金额:$ 27.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-05-01 至 1992-02-29
- 项目状态:已结题
- 来源:
- 关键词:Retroviridae disease T lymphocyte X ray bone marrow cell sorting gene expression genetic manipulation laboratory mouse lymphoma molecular cloning neoplasm /cancer genetics neoplastic growth nucleic acid sequence oncogenes pediatric neoplasm /cancer radiation related neoplasm /cancer tissue /cell culture transforming growth factors viral leukemogenesis virus genetics
项目摘要
Lymphomagenesis is a mulitstep process in which the lymphoma
cells become increasingly tumorigenic with time. In the initial
phases of the disease, growth factor-dependent cells dominate;
During the progression phases chromosome and oncogene
rearrangements prevail. Leukemias possessing chromsomes or
oncogene rearrangements have a poor prognosis compared to
those lacking genetically-fixed rearrangements. Thus, it is of
upmost importance to study the initial, growth-factor dependent
phases of the disease so as to facilitate the design of rational
approaches of intervention before gene rearrangementts occur.
T leukemia/lymphomas of mice that are induced by radiation (an
etiologic agent) initially comprise growth factor-dependent,
autocrine cells. The nature of the growth factor (coined
Lymphoma Growth Factor, LGF) and its cell surface receptor
(LGF-R) will be studied by molecular cloning of genes encoding
them. Molecular clones encoding the LGF and LGF-R will be
studied on the nucleic acid and protein level. Antibodies specific
for the LGF and LGF-R will be prepared. The site(s) at which
LGF/LGF-R-positive cells first evolve in treated mice, as well as
the characteristics of such cells will be studied. The existance
and phenotypes of LGF/LGF-R-positive cells in non-treated mice
will also be studied.
Childhood Acute Lymphoblastic Leukemia of T cells (T-ALL) also
appears to involve an LGF-dependent phase in which a growth
factor similar to the murine LGF is implicated. Thus the study of
the early, growth factor-dependent phase of murine lymphoma
should further our understanding of childhood T-ALL as well.
淋巴瘤的发生是一个多步骤的过程,
随着时间的推移,细胞的致瘤性越来越强。 在初始
在疾病的各个阶段,生长因子依赖性细胞占主导地位;
在进展阶段,染色体和癌基因
重新安排占上风。 具有染色体的白血病或
癌基因重排的预后较差,
那些缺乏基因固定重排的人。 因此,
最重要的是研究初始的,生长因子依赖的
疾病的阶段,以便于设计合理的
在基因突变发生前进行干预的方法。
由辐射诱导的小鼠T白血病/淋巴瘤(一种
病原体)最初包括生长因子依赖性,
自分泌细胞 生长因子的性质(
淋巴瘤生长因子及其细胞表面受体
(LGF-R)将通过编码LGF-R的基因的分子克隆来研究。
他们 编码LGF和LGF-R的分子克隆将在
从核酸和蛋白质水平进行研究。 特异性的抗体
将为LGF和LGF-R准备。 发生以下情况的地点
LGF/LGF-R阳性细胞首先在治疗的小鼠中进化,
将研究这种电池的特性。 的存在性
未处理小鼠中LGF/LGF-R阳性细胞的表型
也将被研究。
儿童T细胞急性淋巴细胞白血病(T-ALL)也
似乎涉及一个生长依赖性阶段,
与鼠LGF相似的因子也有牵连。 因此,研究
小鼠淋巴瘤早期生长因子依赖期
也会进一步加深我们对儿童T-ALL的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin nmi Haas其他文献
Martin nmi Haas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin nmi Haas', 18)}}的其他基金
STUDIES OF AN AFRICAN POPULATION ENDEMIC FOR HTLV
非洲人群 HTLV 流行病的研究
- 批准号:
3183737 - 财政年份:1986
- 资助金额:
$ 27.75万 - 项目类别:
STUDIES OF AN AFRICAN POPULATION ENDEMIC FOR HTLV
非洲人群 HTLV 流行病的研究
- 批准号:
3183736 - 财政年份:1986
- 资助金额:
$ 27.75万 - 项目类别:
VIRAL MALIGNANT LYMPHOMAGENESIS IN X-IRRADIATED MICE
X 射线照射小鼠中的病毒恶性淋巴瘤发生
- 批准号:
3171912 - 财政年份:1982
- 资助金额:
$ 27.75万 - 项目类别:
VIRAL MALIGNANT LYMPHOMAGENESIS IN X-IRRADIATED MICE
X 射线照射小鼠中的病毒恶性淋巴瘤发生
- 批准号:
3171917 - 财政年份:1982
- 资助金额:
$ 27.75万 - 项目类别:
VIRAL MALIGNANT LYMPHOMAGENESIS IN X-IRRADIATED MICE
X 射线照射小鼠中的病毒恶性淋巴瘤发生
- 批准号:
3171915 - 财政年份:1982
- 资助金额:
$ 27.75万 - 项目类别:
VIRAL MALIGNANT LYMPHOMAGENESIS IN X-IRRADIATED MICE
X 射线照射小鼠中的病毒恶性淋巴瘤发生
- 批准号:
3171916 - 财政年份:1982
- 资助金额:
$ 27.75万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 27.75万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 27.75万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 27.75万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 27.75万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 27.75万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 27.75万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 27.75万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 27.75万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 27.75万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 27.75万 - 项目类别:
Discovery Grants Program - Individual